Dr. Benedict Albensi has been appointed to the board of directors of MitoCanada. Albensi is a professor in the department of pharmacology and therapeutics, faculty of health sciences, college of medicine, University of Manitoba and principal investigator, Synaptic Plasticity and Cellular Memory Dysfunction in the neurodegenerative disorders division of St. Boniface Hospital Research Centre.
MitoCanada provides support and awareness to Canadians affected by Mitochondrial Disease while also supporting the advancement of research in the field of Mitochondrial Disease.